CLASS II Device recall · Reported 15 Mar 2017 · FDA Enforcement Report

Dimension Vista LOCI Progesterone recalled

Siemens Healthcare Diagnostics is recalling Dimension Vista LOCI Progesterone, distributed nationwide in the US. The recall was initiated on 4 Jan 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes16193BB 16200BA 16214BA 16235BB 16250BA 16270BA 16291BA 16319AA
Quantity recalled1148

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1419-2017
FDA event ID
76212
Recalling firm
Siemens Healthcare Diagnostics, East Walpole, MA
Classification
Class II
Status
Terminated
Recall initiated
4 Jan 2017
FDA classified
9 Mar 2017
Reported
15 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Jan 2017Recall initiated by company
9 Mar 2017Classified by FDA+64 days
15 Mar 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

DHEA-S causes falsely elevated progesterone results.

Product as listed by the FDA

Dimension Vista LOCI Progesterone; Catalog Number: K6464; Siemens Material Number: 10461743 Product Usage: For in vitro diagnostic use in the quantitative determination of progesterone in serum and using the ADVIA Centaur¿, ADVIA Centaur XP, ADVIA Centaur XPT and ADVIA Centaur CP systems

Where it was distributed

US Nationwide distribution including Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

DHEA-S causes falsely elevated progesterone results.

Which lots are affected?

16193BB 16200BA 16214BA 16235BB 16250BA 16270BA 16291BA 16319AA

Where was it sold?

US Nationwide distribution including Puerto Rico

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 76212

This product is part of a recall event; the main page for the event is Immulite 2000 Progesterone recalled by Siemens Healthcare Diagnostics.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656